Structure of mortality in patients with new coronavirus infection COVID-19 dead in hospital

A comparative analysis of the case histories of patients with coronavirus infection who died and survived in the period 2020-2021 was carried out. The study confirmed the negative impact of comorbid conditions on the course and outcome of a new coronavirus infection COVID-19. Patients with blood diseases are at the greatest risk of adverse outcome. The structure of mortality from a new coronavirus infection COVID-19 is described. Respiratory failure and respiratory distress syndrome play a primary role in the mortality of patients from complications of Covid-19. The reliability of the absence of the influence of age and gender on the course and outcome of a new coronavirus infection COVID-19 is shown. Comparison of laboratory parameters of the blood test between the studied groups of patients revealed a significant difference in the levels of lymphocytes, indicating the development of immune suppression, which led to an unfavorable outcome. Medical-organizational (defects in therapy at the pre-hospital stage) and biological risk factors for deterioration or death from the new coronavirus infection COVID-19 were identified. The inexpediency of treatment with antibacterial drugs at the prehospital stage with a new coronavirus infection COVID-19 is shown. The inadvisability of prescribing antibacterial drugs at the prehospital stage and their negative impact on the severity of the condition upon admission with a new coronavirus infection COVID-19 is shown